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Abstract
Objective
Phenylketonuria is one of the most common metabolic disorders and the first 
known cause of mental retardation in pediatrics. As Screening for phenylketonuria 
(PKU) is not a routine neurometabolic screening test for neonates in Iran, many 
PKU cases may be diagnosed after developing the clinical symptoms. One of the 
findings of PKU is myelination disorders, which is seen as hypersignal regions 
in T2-weighted (T2W) and FLAIR sequences of brain MRI. The aim of our 
study was to assess MRI changes in PKU patients referred to Mofid Children’s 
Hospital, 2010-2011.
Materials & Methods
We studied all PKU cases referred to our clinic as a referral neurometabolic 
center in Iran for brain MRI and assessed the phenylalanine level at the time of 
Imaging. The mean phenylalanine level (in one year), clinical manifestations, 
and MRI pattern based on Thompson scoring, were evaluated.
Results
The mean age of our study group was 155±99 months and the mean diagnosis 
age was 37±27.85 months. There were 15 patients with positive and 15 with 
negative family history. The mean phenylalanine level at the time of imaging 
was 9.75±6.28 and the mean 1 year phenylalanine level was 10.28±4.82. Seventy 
percent of our patients had MRI involvement, in whom 20% showed atrophic 
changes, in addition to white matter involvement. Based on modified Thompson 
scoring, the score for our study group was 4.84.
The maximum involvement in MRI was in occipital region, followed by parietal, 
frontal, and temporal zones. There was not any correlation between MRI score 
and patients’ age. But we found significant relationship between MRI score and 
the age of regimen cessation. No correlation was seen between phenylalanine 
level (at the time of Imaging) and MRI score. But there was a relationship 
between mean 1 year phenylalanine level and MRI score.
Conclusion
According to the results of this study, brain MRI and white matter involvement 
can be used for evaluation of long-term control of phenylalanine level in PKU 
cases.
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demographic parameters.
Materials & Methods
In this cross-sectional study, all PKU cases referred to 
Neurology clinic of Mofid Children Hospital during 
the December 2010-September 2012 were enrolled. 
A questionnaire containing personal information of 
patients, time of diagnosis of disease, time of diet 
initiation, developmental status, mean phenylalanine 
level in the past year, the point phenylalanine level of 
patient at the time of imaging, and clinical manifestations 
of the disease was filled in. Phenylalanine level was 
measured by high-performance liquid chromatography 
(HPLC) method in a reliable laboratory center.
Brain MRI (T1W-T2W-FLAIR) was obtained for each 
patient. All of imagings were performed using a 1.5 
Tesla scanner (Siemens) by conventional protocols in 
coronal, axial and sagittal view (9-11).
White matter involvement was scored based on 
modified Thompson scoring (Table1) by an expert 
neuroradiologist (12).
All collected data were analyzed by t-test and Spearman’s 
and Pearson’s Correlation coefficients using SPSS 18.
known metabolic disorder, and the first treatable inborn 
error of metabolism (1, 2).
Although, we have prenatal diagnosis of PKU and also 
diagnosis by screening methods in the first days of life, 
many of cases remains undiagnosed until they become 
symptomatic. 
Because the screening methods for measurement of 
phenylalanine level were not routine in our country, 
many of cases are diagnosed after developing clinical 
symptoms.
PKU is characterized by mental retardation, 
microcephaly, blond hairs, and specific odor caused by 
the presence of keto acids in urine (3-6).
Severity of MRI findings (white matter involvement) 
correlates with mean phenylalanine level in the past 
years and point phenylalanine level at the time of 
imaging (7, 8).
Many studies showed correlation between phenylalanine 
level and MRI white matter involvement in conventional 
methods and with a higher sensitivity in DWI (9, 10).
In the present study, we aimed to evaluate the correlation 
between white matter involvement in T2-weighted 
(T2W) and FLAIR sequences of brain MRI in our 
patients and its relationship with clinical symptoms and 
Table 1. Thompson scoring based on anatomic involvement
Scan AppearenceGradeScan AppearenceGrade
30-50% White matter involved3Normal0
50-75% White matter involved4<10% White matter involved1
>75% White matter involved510-30% White matter involved2
Six different part (frontal, parietal, temporal, occipital, brain stem, and other parts) of each hemisphere of brain were 
evaluated for white matter involvement and the involvement was graded 1.
Results
We studied 30 patients with PKU who were referred to 
neurology clinic of Mofid Children’s Hospital.
The mean age of our study group was 155±99 months, 
with minimum age of 10 and maximum age of 312 
months.
Thirteen patients (43%) were female and 17 (57%) were 
male.
The mean age of diagnosis in our study was 37±27.85 
months, with minimum age of 1 month and maximum 
age of 168 months.
The mean age of diet initiation was 44.61±33.95 months.
15 Patients (50%) had positive family history of PKU 
and the rest had negative.
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Evaluation of motor and language development showed 
that all developmental millstones happened with delay 
in our study group. Speech delay was more sever.
The mean phenylalanine level over the past year in our 
patients was lower than former studies (3-5). As this study 
was done in pediatric patients, most of our cases were 
under low phenylalanine diet and their phenylalanine 
level were lower than previous studies with wider age 
distribution (4-6).
White matter involvement was seen in 21 (70%) cases 
and this was less than other studies (4,7). This may be 
due to higher phenylalanine level in previous studies.
On the other hand, some of prior studies had been 
designated based on DWI, which is more sensitive than 
conventional MRI imaging causing better detection of 
white matter involvement (5).
In our study, the maximum white matter involvement 
was in occipital region and spreads to parietal and frontal 
areas in higher phenylalanine levels. This is compatible 
with previous studies (11,12).
MRI score (Thompson) had no correlation with patients’ 
age (p=0.176) similar to previous studies (4-6).
MRI score had no significant relation with the age of 
diagnosis (p=0.369), which was consistent with other 
studies (7,8).
Our study shows more time from regimen cessation and 
more sever and extensive MRI involvement.
Our study proved that there is a linear relationship 
between MRI score and age of regimen cessation 
(p=0.006).
We could not find any correlation between MRI score and 
present phenylalanine level (p=0.265). This is contrary 
to findings of previous studies, showed statistical 
correlation between MRI score and point phenylalanine 
level at the time of imaging (9-12).
This may be due to ﬂuctuation in phenylalanine level 
in our studied group, which caused difference between 
point phenylalanine level at the time of imaging and 
mean 1 year phenylalanine level.
There is statistical correlation between MRI involvement 
and mean 1 years phenylalanine level of patients 
(p=0.017), which is compatible with previous studies.
In conclusion, considering cultural and economical 
limitation and trammels, assessment of mean 1 year 
phenylalanine level is the best indicator of white matter 
Consanguineous marriage was seen in parents of 20 
cases (66.7%).
In our study group, the mean age for neck holding was 
5.4±4.26 months, for sitting 11.4±7.76 months and for 
walking 19.43±6.13 months.
Mean phenylalanine level at the time of imaging (MRI) 
was 9.75±6.28 (range, 0.5- 23) mmol/dL.
The mean phenylalanine level in the past 1 year was 
10.28±4.82 mmol/dL.
Twenty-one patients (70%) had MRI involvement and 9 
patients had no pathologic changes in their MRI.
Atrophic cortical changes were seen in 6 (20%) cases of 
our study group. 
Based on FLAIR and T2W sequences in MRI of our 
study group, the mean Thompson score was 4.84±4.63 
(range, 0-18).
The maximum white matter involvement was seen 
in occipital region (63.3%), followed by parietal lobe 
(43.3%). The least involvement was seen in temporal 
area (3.3%).
Ten patients of our study group (33.3%) had seizure, 
which was generalized tonic clonic in 60% of them, and 
complex partial seizure in 2 cases. Infantile spasm and 
myoclonic seizure each one was seen in 1 case.
Eleven (36.7%) patients had abnormal EEG. 
About psychological symptoms, autistic features were 
seen in 7 cases (23.3%) and ADHD in 4 patients.
Discussion
The mean age of diagnosis in our study was 37±27.85 
months and this was a failure for our case finding system. 
The diet therapy must be started within the first week of 
life to prevent neurological and cognitive disturbances.
This shows the importance of screening tests for the 
disease.
Unfortunately, in some cases, in spite of positive family 
history, PKU was diagnosed with obvious delay.
In most previous studies, the age of diagnosis was more 
than 10 years.
20 cases (62.7%) of our study group were products of 
consanguineous marriage, which shows the importance 
of screening tests in this group.
The mean age for starting low phenylalanine diet was 
44.61±33.95 months, which shows a significant delay 
between diagnosis and diet initiation in our patients.
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involvement and has more relation with MRI score 
compared to point phenylalanine level at the time of 
imaging. Therefore, we can use brain MRI and white 
matter involvement for evaluation of long-term control 
of phenylalanine level in PKU cases.
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